Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysis
Congcong Li, Liyan Bo, Qingqing Liu et al.
Research Article — Peer-Reviewed Source
Original research published by Li et al. in International Journal of Infectious Diseases. Redistributed under Open Access — see publisher for license terms. MedTech Research Group provides these references for informational purposes. We do not conduct original research. All studies are the work of their respective authors and institutions.
Tα1 based immunomodulatory therapy was associated with a lower mortality in septic patients. Nevertheless, these findings should be interpreted cautiously because of the poor quality and small number of participants of the included trials. More well-designed worldwide multicenter clinical trials are needed to provide a conclusive guideline for clinical practice.
Full text is available at the publisher.
Read at Publisher| DOI | 10.1016/j.ijid.2014.12.032 |
| Journal | International Journal of Infectious Diseases |
| Year | 2014 |
| Authors | Congcong Li, Liyan Bo, Qingqing Liu, Faguang Jin |
| License | Open Access — see publisher for license terms |
| Citations | 43 |